-

Trinity Life Sciences Announces Participation in 2021 MIT Sloan CFO Summit

Rebecca McNamara, CFO, to Speak at Premier CFO Conference on November 18, 2021

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced that Rebecca McNamara, Chief Financial Officer at Trinity, will be a featured speaker at the 19th annual MIT Sloan CFO Summit, the nation’s premier one-day CFO conference. This year’s conference, titled “Optimism and Excellence,” features the role of CFOs in uplifting their companies and instilling enterprise excellence.

Ms. McNamara will be presenting on the topic of Upskilling the Team.

“I’m honored to participate in the MIT Sloan CFO Summit with so many of my accomplished peers,” said Rebecca McNamara, Chief Financial Officer, Trinity Life Sciences. “Today’s corporate financial environment is as dynamic as ever and Summits like these help leaders share best practices and have meaningful discussions about the strategic issues facing finance executives.”

Other speakers on the program include the CFOs from Bristol Myers Squibb, Desktop Metal, Hologic, Spotify, Stripe, SoundCloud, SQZ Biotech, Vimeo, Workhuman and many more.

Founded in 2002, the CFO Summit brings together leading faculty from MIT and financial executives from around the world. The annual event offers a day of practical education, peer networking and thought-provoking discourse on the future of finance, accounting, and business. The day includes presentations, panels, keynote speakers and networking.

The Summit is part of the CXO Series by the MIT Sloan School of Management, one of the world’s leading academic sources of innovation in management theory and practice, and the MIT Sloan Boston Alumni Association. The annual events, organized by alumni volunteers, promote the MIT philosophy of “mens et manus,” or “mind and hand,” by bringing together the academic research from MIT Sloan with today’s corporate leaders.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Summary
Rebecca McNamara, CFO of Trinity Life Sciences to speak at premier CFO conference on November 18, 2021.
Release Versions

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom